Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023927 · ClinicalTrials.gov registry record
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
A clinical trial, sponsored by Northwell Health.
- Not yet
- Registry status
- 100
- Enrollment target
NCT06023927 is a clinical trial that has not yet begun recruiting, run by Northwell Health. The registered enrollment target is 100 participants.
The verdict
NCT06023927 has not yet begun recruiting, sponsored by Northwell Health.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about the relationship between Obstructive Sleep Apnea (OSA) and Normal Tension Glaucoma (NTG). OSA is a nighttime disorder of the upper airway that causes an intermittent lack of oxygen while sleeping. NTG is a type of glaucoma that occurs despite the normal intraocular pressure levels, making its detection more difficult. Left untreated, irreversible optic nerve damage and extensive vision loss can result. Previous research has shown some evidence between OSA and the development of NTG. The investigators are researching whether undergoing treatment for OSA would help to improve the vascular health to the retina, and in effect, improve the early signs of visual dysfunction seen with diagnostic testing.
Interventions
- OTHER Clinical observation, diagnostic testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2028-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06023927
The ClinicalTrials.gov registry entry for NCT06023927 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical observation, diagnostic testing is the first listed.
NCT06023927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06023927 about?
NCT06023927 is a clinical study titled "Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness". The purpose of this research study is to learn more about the relationship between Obstructive Sleep Apnea (OSA) and Normal Tension Glaucoma (NTG). OSA is a nighttime disorder of the upper airway that causes an intermittent lack of oxygen while sleeping. NTG is a type of glaucoma that occurs despite...
What is the current status of trial NCT06023927?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2025-09-02. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT06023927?
The interventions under investigation include: Clinical observation, diagnostic testing (OTHER).
Who is sponsoring clinical trial NCT06023927?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.